Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top biotechnology companies in the world based on market capitalization as of 2018
(in billion U.S. dollars)
Largest biotech companies in the world by market capitalization 2018
This statistic depicts the global top 10 biotechnology companies based on market capitalization as of late October 30, 2018 . At this point, Danish biopharmaceutical manufacturer Novo Nordisk was ranked third among such companies, with a market capitalization of around 81.4 billion U.S. dollars. Novo Nordisk also ranks among the top biotech companies by profit.

Global biotechnology

Gilead Sciences and Novo Nordisk are two of the largest biotechnology companies in the world. In June 2015, Gilead Sciences, a company based in the U.S., had a market capitalization of nearly 150 billion U.S. dollars, while Novo Nordisk had market capitalization of 144 billion U.S. dollars. As of 2012, there were 2,178 companies in the United States dedicated to biotechnology developments, and in comparison, Germany had 570 companies. Biotech companies located in Los Angeles and Orange County generated 20.3 billion U.S. dollars in revenue, while companies in New England generated almost 17 billion U.S. dollars in 2014.

In the United States, developments for medical biotechnology are a significant component of the biotech industry. Jobs in research, testing, and medical laboratories have increased significantly. Humira, an anti-inflamatory drug, was developed by AbbVie and has generated 12.5 billion U.S. dollars in revenue in 2014. The biopharmaceutical market is expected to continue to grow due to new innovations and the demand for quality medical technologies. Biotechnology is also commonly used in agriculture. Biotech crops in the United States accounts for more than half of the world’s total. With a total of 90.6 million acres of corn crops in the United States, only 6.3 million acres are considered non-biotech fields. Biotechnology also extends into the industrial sector, providing innovation for nanotechnology, enzymes, and biofuels.
Top biotechnology companies in the world based on market capitalization as of 2018
(in billion U.S. dollars)
Market capitalization in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

November 2018

Region

Worldwide

Survey time period

as of October 30, 2018

Supplementary notes

All figures as of end-October, 2018.

Largest biotech companies in the world by market capitalization 2018
This statistic depicts the global top 10 biotechnology companies based on market capitalization as of late October 30, 2018 . At this point, Danish biopharmaceutical manufacturer Novo Nordisk was ranked third among such companies, with a market capitalization of around 81.4 billion U.S. dollars. Novo Nordisk also ranks among the top biotech companies by profit.

Global biotechnology

Gilead Sciences and Novo Nordisk are two of the largest biotechnology companies in the world. In June 2015, Gilead Sciences, a company based in the U.S., had a market capitalization of nearly 150 billion U.S. dollars, while Novo Nordisk had market capitalization of 144 billion U.S. dollars. As of 2012, there were 2,178 companies in the United States dedicated to biotechnology developments, and in comparison, Germany had 570 companies. Biotech companies located in Los Angeles and Orange County generated 20.3 billion U.S. dollars in revenue, while companies in New England generated almost 17 billion U.S. dollars in 2014.

In the United States, developments for medical biotechnology are a significant component of the biotech industry. Jobs in research, testing, and medical laboratories have increased significantly. Humira, an anti-inflamatory drug, was developed by AbbVie and has generated 12.5 billion U.S. dollars in revenue in 2014. The biopharmaceutical market is expected to continue to grow due to new innovations and the demand for quality medical technologies. Biotechnology is also commonly used in agriculture. Biotech crops in the United States accounts for more than half of the world’s total. With a total of 90.6 million acres of corn crops in the United States, only 6.3 million acres are considered non-biotech fields. Biotechnology also extends into the industrial sector, providing innovation for nanotechnology, enzymes, and biofuels.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Biotech industry"
  • Global overview
The most important statistics
  • U.S. companies
  • Research & development
  • Products
  • Funding/investment
  • Biotech in agriculture
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.